TotalMarketCap

Atea Pharmaceuticals

AVIRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$338.865 M

$4.23 -5.27%

Close of 6 Nov 2026

As of 6 Nov 2026, Atea Pharmaceuticals (AVIR) has a market capitalization of $338.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$158.0M

Loss-making

Shares outstanding

80,204,699

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #212RezoluteRZLT$354.5M
  2. #213Contineum TherapeuticsCTNM$353.2M
  3. #214Atea PharmaceuticalsAVIR$338.9M
  4. #215Aspen NeuroscienceASPE$335.0M
  5. #216Opus GeneticsIRD$334.0M

What if Atea Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$352,060.09

Per share 83,328× higher

Bitcoin $1.53T

$19,049.36

Per share 4,509× higher

Apple $5.02T

$62,537.27

Per share 14,802× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Atea Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.